| Literature DB >> 32030195 |
Camille Nebeker1, Sarah E Dunseath2, Rubi Linares-Orozco3.
Abstract
OBJECTIVE: Social network platforms are increasingly used in digital health research. Our study aimed to 1. qualify and quantify the use of social media platforms in health research supported by the National Institutes of Health (NIH) and document changes occurring between 2011 and 2017 and 2. examine whether institutions hosting these studies provided public-facing guidelines on how to conduct ethical social media health research.Entities:
Keywords: Facebook; IRB; Instagram; Pinterest; Social media platform; Twitter; big data; digital health; research ethics
Year: 2020 PMID: 32030195 PMCID: PMC6977220 DOI: 10.1177/2055207619901085
Source DB: PubMed Journal: Digit Health ISSN: 2055-2076
Figure 1.Process of inclusion of NIH-funded social media research.
Themes in social media research as identified by keyword search 2011–2017.
| Broad theme | Substance use | Disease/diagnosis | Weight & activity | Psychiatry & mental health |
|---|---|---|---|---|
| Terms | Substance use/abuseAlcohol Smoking TobaccoMarijuanaOpioid/opiateHeroinCocaineMethamphetamineEcstasy/MDMAe-cigarettesLSDPrescription pillsStimulants | CancerOncologyCarcinomaSarcomaDiabetesHIVCardiovascular diseaseHypertensionHeart diseaseOsteoporosisVaccination/immunization | Physical activityWeight lossWeight gainObesitySedentary behavior | PsychiatryPsychologyMental healthDepressionPost-traumatic stress disorderAnxietySuicide/suicidalBipolar disorder |
NIH-funded social media studies targeting specific populations.
| Year/key term | African American | Hispanic | Infants/children | Young adults/adolescents/teenagers | MSM, lesbian, transgender, gay | Pregnant, pregnancy |
|---|---|---|---|---|---|---|
| 2011 | 1 (11.1) | 1 (11.1) | 0 (0) | 3 (33.3) | 1 (11.1) | 0 (0.0) |
| 2012 | 3 (20.0) | 1 (6.7) | 0 (0) | 7 (46.7) | 5 (33.3) | 0 (0.0) |
| 2013 | 3 (16.7) | 1 (5.6) | 1 (5.6) | 9 (50.0) | 3 (16.7) | 1 (5.6) |
| 2014 | 2 (15.4) | 1 (3.3) | 1 (3.3) | 13 (43.3) | 2 (6.7) | 1 (3.3) |
| 2015 | 8 (16.3) | 3 (6.1) | 2 (4.1) | 25 (51.0) | 6 (12.2) | 0 (0) |
| 2016 | 7 (15.2) | 2 (4.3) | 1 (2.2) | 26 (56.5) | 5 (10.9) | 2 (4.3) |
| 2017 | 11 (18.3) | 5 (8.3) | 1 (1.7) | 34 (56.7) | 8 (13.3) | 3 (5.0) |
| Total unique studies accounting for duplicates across multiple years | 15 (14.3) | 7 (6.7) | 2 (1.9) | 51 (48.6) | 16 (15.2) | 4 (3.8) |
The following keywords did not yield any projects: e-cigarettes, stimulants, prescription pills, LSD, MDMA, bipolar disorder, oncology, sarcoma, osteoporosis, sedentary behavior, geriatric, Indian, Middle Eastern.
Use of social media in NIH-funded research.
| Year/use | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|---|
| Intervention | 6 (66.7) | 8 (53.3) | 8 (44.4) | 10 (33.3) | 18 (36.7) | 20 (43.5) | 30 (50.0) |
| Platform assessment | 5 (55.6) | 6 (40.0) | 6 (33.3) | 11 (36.7) | 18 (36.7) | 19 (41.3) | 27 (45.0) |
| Recruitment | 1 (11.1) | 2 (13.3) | 3 (16.7) | 6 (20.0) | 12 (24.5) | 12 (26.1) | 18 (30.0) |
| Surveillance | 4 (44.4) | 7 (46.7) | 9 (50.0) | 17 (56.7) | 24 (49.0) | 23 (50.0) | 22 (36.7) |
Use of social media research in adolescents/young adults 2011–2017.
| Year/keyword | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|---|
| Substance use | |||||||
| Alcohol | 2 (66.7) | 4 (57.1) | 4 (44.4) | 7 (53.8) | 10 (40.0) | 12 (46.2) | 13 (38.2) |
| Tobacco/smoking | 1 (33.3) | 1 (14.3) | 1 (11.1) | 6 (46.2) | 6 (24.0) | 7 (26.9) | 9 (26.5) |
| Marijuana | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (23.1) | 4 (16.0) | 3 (11.5) | 4 (11.8) |
| Opioids | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Cocaine | 0 (0.0) | 1 (14.3) | 1 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Methamphetamine | 0 (0.0) | 1 (14.3) | 1 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Ecstasy/MDMA | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (4.0) | 0 (0.0) | 0 (0.0) |
| Psychology/mental health | |||||||
| Depression | 1 (33.3) | 4 (57.1) | 4 (44.4) | 3 (23.1) | 3 (12.0) | 3 (11.5) | 3 (8.8) |
| PTSD | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.9) |
| Anxiety | 0 (0.0) | 1 (14.3) | 1 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.9) |
| Suicide | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.9) |
| Schizophrenia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Disease/ diagnosis | |||||||
| Cancer | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (7.7) | 5 (14.7) |
| Diabetes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (4.0) | 1 (3.8) | 2 (5.7) |
| HIV | 1 (33.3) | 3 (42.9) | 2 (22.2) | 2 (15.4) | 7 (28.0) | 5 (19.2) | 6 (17.6) |
| Cardiovascular hypertension, heart failure | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (4.0) | 1 (3.8) | 2 (5.9) |
| Vaccination/ Immunization | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (4.0) | 0 (0.0) | 1 (2.9) |
| Physical activity/weight | |||||||
| Physical activity | 1 (33.3) | 1 (14.3) | 2 (22.2) | 1 (7.7) | 1 (4.0) | 1 (3.8) | 2 (5.9) |
| Weight loss | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (4.0) | 1 (3.8) | 1 (2.9) |
| Weight gain | 1 (33.3) | 1 (14.3) | 2 (22.2) | 3 (23.1) | 3 (12.0) | 2 (7.7) | 2 (5.9) |
| Obesity | 0 (0.0) | 0 (0.0) | 1 (11.1) | 3 (23.1) | 4 (16.0) | 3 (11.5) | 2 (5.9) |
| Use of social media | |||||||
| Intervention | 2 (66.7) | 3 (42.9) | 4 (44.4) | 6 (46.2) | 13 (52.0) | 16 (61.5) | 20 (58.8) |
| Platform assessment | 1 (33.3) | 3 (42.9) | 3 (33.3) | 7 (53.8) | 10 (40.0) | 11 (42.3) | 11(32.4) |
| Recruitment | 0 (0.0) | 1 (14.3) | 2 (22.2) | 3 (23.1) | 6 (24.0) | 7 (26.9) | 9 (26.5) |
| Surveillance | 2 (66.7) | 4 (57.1) | 4 (44.4) | 5 (38.5) | 8 (32.0) | 9 (34.6) | 16 (47.1) |
Use of social media research in MSM 2011–2017.
| Year/key term | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|---|
| Substance use | |||||||
| Alcohol | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 1 (0.20) | 1 (12.5) |
| Cocaine | 0 (0.0) | 1 (20.0) | 1 (33.3) | 0 (0.0) | 1 (16.7) | 1 (0.20) | 0 (0.0) |
| Ecstasy | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 1 (0.20) | 0 (0.0) |
| Methamphetamine | 0 (0.0) | 1 (20.0) | 1 (33.3) | 0 (0.0) | 1 (16.7) | 1 (0.20) | 0 (0.0) |
| Smoking/tobacco | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) |
| Psychology/mental health | |||||||
| Mental health | 0 (0.0) | 1 (20.0) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) |
| PTSD | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Suicide | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Disease/diagnosis | |||||||
| HIV |
|
|
|
|
|
|
|
| Cancer | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) |
| Physical activity/weight | |||||||
| Physical activity | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) |
| Use of social media in research | |||||||
| Intervention | 3 (100.0) | 3 (60.0) | 1 (33.3) | 2 (100.0) | 3 (50.0) | 3 (60.0) | 6 (75.0) |
| Platform assessment | 1 (33.3) | 2 (40.0) | 2 (66.7) | 2 (100.0) | 2 (33.3) | 2 (40.0) | 3 (37.5) |
| Recruitment | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (33.3) | 3 (60.0) | 4 (50.0) |
| Surveillance | 1 (33.3) | 3 (60.0) | 2 (66.7) | 0 (0.0) | 2 (33.3) | 0 (0.0) | 3 (37.5) |
Number of substance use projects receiving NIH funding from 2011–2017.
| Year/key term | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total unique studies across all years accounting for duplicates |
|---|---|---|---|---|---|---|---|---|
| Alcohol | 2 (40.0) | 4 (44.4) | 4 (36.4) | 12 (75.0) | 17 (81.0) | 18 (75.0) | 14 (56.0) | 32 (65) |
| Smoking/tobacco | 4 (80.0) | 6 (66.7) | 8 (72.7) | 10 (62.5) | 10 (47.6) | 11 (45.8) | 14 (56.0) | 27 (54) |
| Marijuana | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (25.0) | 5 (23.8) | 5 (20.8) | 5 (20.0) | 9 (18) |
| Opioid | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (12.5) | 2 (9.5) | 2 (8.3) | 0 (0.0) | 2 (4) |
| Cocaine | 0 (0.0) | 1 (11.1) | 1 (9.1) | 1 (6.3) | 2 (9.5) | 2 (8.3) | 0 (0.0) | 3 (6) |
| Meth-amphetamine | 0 (0.0) | 1 (11.1) | 1 (9.1) | 0 (0.0) | 1 (4.8) | 1 (4.2) | 0 (0.0) | 2 (4) |
| Heroin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (6.3) | 1 (4.8) | 1 (4.2) | 0 (0.0) | 1 (2) |
| Ecstasy | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (6.3) | 2 (9.5) | 1 (4.2) | 0 (0.0) | 2 (4) |
Number of disease/diagnosis projects receiving NIH funding from 2011–2017.
| Year/key term | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total unique studies across all years accounting for duplicates |
|---|---|---|---|---|---|---|---|---|
| Cancer | 1 (25.0) | 1 (14.2) | 1 (20.0) | 3 (30.0) | 3 (13.6) | 5 (29.4) | 9 (34.6) | 12 (27.9) |
| Diabetes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (40.0) | 6 (27.3) | 4 (23.5) | 7 (26.9) | 10 (23.3) |
| HIV | 3 (75.0) | 6 (85.7) | 4 (80.0) | 3 (30.0) | 12 (54.5) | 8 (47.1) | 10 (38.5) | 21 (48.8) |
| Cardiovascular disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 2 (9.1) | 2 (11.8) | 5 (19.2) | 5 (11.6) |
| Vaccinations/immunizations | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 2 (9.1) | 1 (5.9) | 2 (7.7) | 3 (7.0) |
Number of social media studies on physical activity and weight receiving NIH funding 2011–2017.
| Year/key term | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total unique studies across all years accounting for duplicates |
|---|---|---|---|---|---|---|---|---|
| Physical activity | 1 (100.0) | 1 (100.0) | 3 (100.0) | 1 (33.3) | 4 (57.1) | 3 (60.0) | 6 (75.0) | 10 (71.4) |
| Obesity | 0 (0.0) | 0 (0.0) | 2 (66.7) | 3 (100.0) | 5 (71.4) | 4 (80.0) | 5 (62.5) | 10 (71.4) |
| Weight gain | 1 (100.0) | 1 (100.0) | 1 (33.3) | 3 (100.0) | 3 (42.9) | 3 (60.0) | 4 (50.0) | 7 (50.0) |
| Weight loss | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 2 (28.6) | 4 (80.0) | 4 (50.) | 4 (28.6) |